1. Home
  2. CENN vs TPST Comparison

CENN vs TPST Comparison

Compare CENN & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cenntro Electric Group Limited

CENN

Cenntro Electric Group Limited

HOLD

Current Price

$3.88

Market Cap

7.5M

ML Signal

HOLD

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.36

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENN
TPST
Founded
2013
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
30.9M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
CENN
TPST
Price
$3.88
$2.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
1.3M
267.3K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,080,161.00
$295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$1.50
52 Week High
$4.42
$12.22

Technical Indicators

Market Signals
Indicator
CENN
TPST
Relative Strength Index (RSI) 89.74 63.14
Support Level $0.26 $2.14
Resistance Level N/A $2.49
Average True Range (ATR) 0.16 0.19
MACD 0.46 0.10
Stochastic Oscillator 85.43 88.54

Price Performance

Historical Comparison
CENN
TPST

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: